The Neurobiology of Migraine and Transformation of Headache Therapy

From NEUROSCIENCE To NEUROLOGY

Volumn , Issue , 2005, Pages 107-123

  Bolay, Hayrunnisa ^a   Moskowitz, Michael A ^b  

^a GAZI UNIVERSITY   (Turkey)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882528480     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012738903-5/50007-2     Document Type: Chapter

References (73)

1. Ayata C, et al. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the 1A subunit of P/Q type calcium channels. Neuroscience 2000, 95:639-645.
2. Bolay H, Moskowitz MA Mechanisms of pain modulation in chronic syndromes. Neurology 2002, 59(5 Suppl 2):S2-S7.
3. Bolay H, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nature Med 2002, 8(2):136-142.
4. Burstein R, Yamamura H, Malick A, Strassman AM Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998, 79:964-982.
5. Burstein R, et al. An association between migraine and cutaneurs allodynia. Ann Neurol 2000, 47:614-624.
6. Buzzi MG, Moskowitz MA Evidence for 5-HT1B/1D receptors mediating the antimigranine effect of sumatriptan and dihydroergoamine. Cephalalgia 1991, 11:165-168.
7. Buzzi MG, Dimitriadou V, Theoharides TC, Moskowitz MA 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain Res 1992, 583:137-149.
8. Cao Y, Welch KM, Aurora S, Vikingstad EM Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999, 56:548-554.
9. Cao Y, et al. Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology 2002, 59:72-78.
10. Curran DA, Hinterberger H, Lance JW Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain 1965, 88:997-1010.
11. De Fusco M, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit gene is responsible for familial hemiplegic migraine type 2. Nature Genet 2003, 33:192-196.
12. Diamond S, et al. Intranasal civamide for the acute treatment of migraine headache. Cephalalgia 2000, 20:597-602.
13. Dove LS, Abbott LC, Griffith WH Whole-cell and single-channel analysis of P-type calcium currents in cerebellar Purkinje cells of leaner mutant mice. J Neurosci 1998, 18:7687-7699.
14. Dunn AK, Bolay H, Moskowitz MA, Boas DA Dynamic imaging of cerebral blood flow using laser speckle. J Cereb Blood Flow Metab 2001, 21:195-201.
15. Feindel W, Penfield W, McNaughton F The tentorial nerves and localization of intracranial pain in man. Neurology 1960, 10:555-563.
16. Goadsby PJ, Edvinsson L, Ekman R Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990, 28:183-187.
17. Goadsby PJ, et al. Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 2002, 125:1392-1401.
18. Gold M, Reichling DB, Shuster MJ, Levine JD Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci U S A 1996, 93:1108-1112.
19. Grafstein B, et al. Meningeal cells can communicate with astrocytes by calcium signaling. Ann Neurol 2000, 47:18-25.
20. Gursoy-Ozdemir Y, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004, 113:1447-1455.
21. Hadjikhani N, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001, 98:4687-4692.
22. Headache Classification Committee of the International Headache Society The International Classification of Headache Disorders 2nd edition. Cephalagia 24 2004, (suppl 1):24-36.
23. Hoyer D, et al. VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 1994, 46:157-203.
24. Hrycaj P, et al. Pathogenetic aspects of responsiveness to ondansetron (5-HT3 antagonist) in patients with primary fibromyalgia syndrome. J Rheumatol 1996, 23:1418-1423.
25. Iedecola C From CSD to headache: a long and winding road. Nature Med 2002, 8(2):110-112.
26. Johnson KW, Phebus LA, Cohen ML Serotonin in migraine: theories, animal models and emerging therapies. Prog Drug Res 1998, 51:221-244.
27. Jones MG, et al. Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat. Cephalalgia 2001, 21:643-655.
28. Kaube H, et al. Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus?. Neurology 2002, 58:1234-1338.
29. Kraig RP, Nicholson C Extracellular ionic variations during spreading depression. Neuroscience 1978, 3:1045-1059.
30. Kruuse C, Thomsen LL, Birk S, Olesen J Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 2003, 126:241-247.
31. Kunkler PE, Kraig RP Hippocampal spreading depression bilaterally activates the caudal trigeminal nucleus in rodents. Hippocampus 2003, 2003.
32. Lambert GA, Donaldson C, Boers PM, Zagami AS Activation of trigeminovascular neurons by glyceryl trinitrate. Brain Res 2000, 887(1):203-210.
33. Lassen LH, et al. Nitric oxide synthase inhibition in migraine. Lancet 1997, 349:401-402.
34. Lassen LH, et al. CGRP may play a causative role in migraine. Cephalalgia 2002, 22:54-61.
35. Lauritzen M, Hansen AJ, Kronborg D, Wieloch T Cortical spreading depression is associated with arachidonic acid accumulation and preservation of energy charge. J Cereb Blood Flow Metab 1990, 10:115-122.
36. Lauritzen M, Olesen J Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain 1984, 107:447-461.
37. Leao A Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944, 7:359-390.
38. Levy D, Jakubowski M, Burstein R Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists. Proc Natl Acad Sci U S A 2004, 101(12):4274-4279.
39. Liu-Chen LY, Han DH, Moskowitz MA Pia arachnoid contains substance P originating from trigeminal neurons. Neuroscience 1983, 9:803-808.
40. Longmore J, et al. Differential distribution of 5-HT1D and 1B immunoreactivity within human trigeminocerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalagia 1997, 17:833-842.
41. Magistretti PJ, Pellerin L Astrocytes couple synaptic activity to glucose utilisation in the brain. News Physiol Sci 1999, 14:177-182.
42. Markowitz S, Saito K, Moskowitz MA Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 1987, 7:4129-4136.
43. Mayberg M, Langer RS, Zervas NT, Moskowitz MA Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science 1981, 213:228-230.
44. Menniti FS, et al. CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents. Neuropharmacology 2000, 39:1147-1155.
45. Moreno MJ Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment. Neuropharmacology 2002, 42(4):568-576.
46. Moskowitz MA, Bolay H, Dalkara T Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol 2004, 55:276-280.
47. Moskowitz MA The neurobiology of vascular head pain. Ann Neurol 1984, 16:157-168.
48. Moskowitz MA The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 1991, 41:182-186.
49. Moskowitz MA Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992, 13:307-311.
50. Moskowitz MA, Macfarlane R Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev 1993, 5:159-177.
51. Moskowitz MA, Nozaki K, Kraig RP Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 1993, 13:1167-1177.
52. Olesen J, et al. Calcitonin gene-related peptide receptor anatagonist BIBN409BS for the acute treatment of migraine. N Engl J Med 2004, 350(11):1104-1110.
53. Olesen J, Iversen HK, Thomsen LL Nitric oxide supersensitivity: a possible molecular mechanisms of migraine pain. Neuroreport 1993, 4:1027-1030.
54. Ophoff RA, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the calcium channel gene. CACNLIOA4, Cell 1996, 87:543-552.
55. Penfield W, McNaughton F Dural headache and innervation of the dura mater. Arch Neurol Psychiatry 1940, 44:43-75.
56. Qian J, Noebels JL Presynaptic Ca2+ channels and neurotransmitter release at the terminal of a mouse cortical neuron. J Neurosci 2001, 21:3721-3728.
57. Ray BS, Wolff HG Experimental studies on headache: pain sensitive structures of the head and their significance in headache. Arch Surg 1940, 41:813-856.
58. Read SJ, Smith MI, Hunter AJ, Parsons AA Enhanced nitric oxide release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetized cat. Cephalalgia 1997, 17:159-165.
59. Reuter U, et al. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 2001, 124(Pt 12):2490-2502.
60. Reuter U, Chiarugi A, Bolay H, Moskowitz MA NF-κ{script}B as a molecular target for migraine therapy. Ann Neurol 2002, 51(4):507-516.
61. Schurr A, Payne RS, Miller JJ, Rigor BM Brain lactate is an obligatory aerobic energy substrate for functional recovery and after hypoxia: further in vitro validation. J Neurochem 1997, 69:423-426.
62. Shepheard S, et al. Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370. Cephalalgia 1999, 19:851-858.
63. Stock JL, et al. The prostaglandin E2EP1 receptor mediates pain perception and regulates blood pressure. J Clin Invest 2000, 107:325-331.
64. Strassman AM, Raymond SA, Burstein R Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996, 384:560-564.
65. Strong AJ, et al. Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke 2002, 33:2738-2743.
66. Suzuki N, Hardebo JE, Owman C Origins and pathways of cerebrovascular nerves storing substance P and calcitonin generelated peptide in rat. Neuroscience 1989, 31:427-438.
67. Tottene A, et al. Familial hemiplegic migraine mutations increase Ca2+ influx through single human Cav2.1 channels and decrease maximal Cav2.1 current density in neurons. Proc Natl Acad Sci U S A 2002, 99:13284-13289.
68. Vergnolle N, et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pathway. Nature Med 2001, 7(7):821-826.
69. Waxman SG, Dib-Hajj S, Cummins TR, Black JA Sodium channels and pain. Proc Natl Acad Sci U S A 1999, 96:7635-7639.
70. Wei F, et al. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Natl Neurosci 2001, 4:164-169.
71. Weiller C, et al. Brain stem activation in spontaneous human migraine attacks. Nature Med 1995, 1:658-660.
72. Welch KM, et al. MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology 1998, 51:1465-1469.
73. Woolf CJ, Salter MW Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1768.